England
| Name | Distance Points | Day Points | Encourager Points | Total Points |
|---|---|---|---|---|
| Total Score | 0 | 0 | 0 | 0 |
| first_14204 last_14204 | 0 | 0 | 0 | 0 |
| first_375568 last_375568 | 0 | 0 | 0 | 0 |
| first_425948 last_425948 | 0 | 0 | 0 | 0 |
| first_468985 last_468985 | 0 | 0 | 0 | 0 |
| Name | Department | Last login | ||
|---|---|---|---|---|
| first_717826 last_717826 | SFC (UK) | 1 year | Message | |
| first_468985 last_468985 | SFC (UK) | 23 days | Message | |
| first_375568 last_375568 | Strategy Portfolio & Operations | 29 days | Message | |
| first_14204 last_14204 | Medicine Design | 5 months | Message | |
| first_425948 last_425948 | CGT | 6 months | Message | |
| first_101680 last_101680 | 7 months | Message | ||
| first_503754 last_503754 | SFC (UK) | 1 year | Message | |
| first_427821 last_427821 | BPR | over 1 year | Message | |
| first_422257 last_422257 | WREF | almost 2 years | Message | |
| first_687691 last_687691 | almost 2 years | Message |
| Name | staff | Riders | Distance (miles) | Trips | Transport Trips |
|---|---|---|---|---|---|
| CMC Analytical | 100 | 0 | 0 | 0 | 0 |
| PSDE | 50 | 1 | 104 | 32 | 0 |
| PTS-DDS | 250 | 1 | 186 | 19 | 10 |
| AS | 100 | 1 | 69 | 3 | 2 |
| CSci | 400 | 0 | 0 | 0 | 0 |
| BPR | 3 | 3 | 6675 | 361 | 99 |
| GAC | 50 | 2 | 1188 | 44 | 5 |
| Biopharm Innovation | 50 | 1 | 4 | 1 | 1 |
| Respiratory | 30 | 6 | 8662 | 686 | 318 |
| Respiratory | 30 | 3 | 2699 | 221 | 66 |
| DMS | 12 | 0 | 0 | 0 | 0 |
| R&D S&P | 12 | 2 | 20 | 7 | 5 |
| ATD | 40 | 3 | 76 | 8 | 8 |
| AIML | 15 | 0 | 0 | 0 | 0 |
| Emcor Engineering | 120 | 0 | 0 | 0 | 0 |
| SM Tech | 50 | 0 | 0 | 0 | 0 |
| CGT | 400 | 6 | 7593 | 790 | 354 |
| AIRU | 120 | 3 | 1695 | 109 | 93 |
| Bioimaging | 30 | 2 | 1038 | 114 | 34 |
| QPPV Office | 8 | 0 | 0 | 0 | 0 |
| CDQA | 30 | 0 | 0 | 0 | 0 |
| Epinova | 100 | 2 | 1165 | 338 | 139 |
| GDS | 3 | 0 | 0 | 0 | 0 |
| LAS | 60 | 0 | 0 | 0 | 0 |
| Product Development | 50 | 4 | 17147 | 571 | 139 |
| TSci | 200 | 1 | 6 | 1 | 1 |
| CPEM Biomarkers | 9 | 1 | 130 | 25 | 0 |
| SFC (UK) | 48 | 7 | 18402 | 1447 | 418 |
| Biopharm R&D | 3 | 2 | 7198 | 327 | 49 |
| ComputationalBiology | 40 | 1 | 1066 | 66 | 1 |
| RMA | 15 | 0 | 0 | 0 | 0 |
| BSci | 80 | 0 | 0 | 0 | 0 |
| SEMA QA | 3 | 0 | 0 | 0 | 0 |
| Data & Computational Science | 400 | 5 | 4655 | 277 | 17 |
| Drug Substance and Product Analysis | 100 | 1 | 1813 | 95 | 49 |
| CPEM Discovery Medicine | 15 | 2 | 33 | 7 | 1 |
| IVSD | 20 | 1 | 5 | 2 | 2 |
| BIB | 12 | 1 | 4545 | 329 | 37 |
| Medicine Design | 600 | 5 | 11719 | 1217 | 972 |
| WREF | 200 | 4 | 15826 | 3170 | 2276 |
| Strategy Portfolio & Operations | 3 | 1 | 10092 | 329 | 8 |
| Discovery DMPK | 25 | 1 | 163 | 40 | 40 |
| C3 | 20 | 1 | 8 | 4 | 4 |
| SPMB | 60 | 1 | 1159 | 45 | 8 |
| GSK Tech | 50 | 2 | 1443 | 102 | 15 |
| Tech Stewards | 8 | 1 | 6 | 1 | 1 |
| Biostatistics | 100 | 1 | 1 | 1 | 0 |
| IBPS | 3 | 1 | 20 | 1 | 0 |
| This can be deleted. | 1 | 0 | 0 | 0 | 0 |
